SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tam, L-S
Right arrow Articles by Li, E K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tam, L-S
Right arrow Articles by Li, E K
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome

L-S Tam

E K Li

Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

Severe pulmonary hypertension (PHT) occurring in patients with systemic lupus erythematosus (SLE) is uncommon. Different modalities have been tried in the treatment for this condition but have not been effective because of progressive increase of pulmonary resistance over time. Our patient with SLE and PHT with antiphospholipid syndrome (APS), a condition which has previously never been described, responded rapidly to combination treatment with immuno-suppression, anticoagulation and vasodilator therapy.

Key Words: pulmonary hypertension • SLE • antiphospholipid syndrome

Lupus, Vol. 7, No. 7, 495-497 (1998)
DOI: 10.1191/096120398678920442
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
C C Mok and C S Lau
Lupus in Hong Kong Chinese
Lupus, September 1, 2003; 12(9): 717 - 722.
[Abstract] [PDF]

Home page
 Ann Rheum DisHome page
G Espinosa, R Cervera, J Font, and R A Asherson
The lung in the antiphospholipid syndrome
Ann Rheum Dis, March 1, 2002; 61(3): 195 - 198.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. P Keane and J. P Lynch III
Rare diseases bullet 7: Pleuropulmonary manifestations of systemic lupus erythematosus
Thorax, February 1, 2000; 55(2): 159 - 166.
[Full Text]


Advertisement